[go: up one dir, main page]

EP1395276A4 - Struktur-modifizierte peptide und ihre verwendungen - Google Patents

Struktur-modifizierte peptide und ihre verwendungen

Info

Publication number
EP1395276A4
EP1395276A4 EP02731790A EP02731790A EP1395276A4 EP 1395276 A4 EP1395276 A4 EP 1395276A4 EP 02731790 A EP02731790 A EP 02731790A EP 02731790 A EP02731790 A EP 02731790A EP 1395276 A4 EP1395276 A4 EP 1395276A4
Authority
EP
European Patent Office
Prior art keywords
modified peptides
structurally modified
structurally
peptides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02731790A
Other languages
English (en)
French (fr)
Other versions
EP1395276A1 (de
Inventor
Jean E Gairin
Jean-Sebastien Blachet
I Dufau
C Nguyen
B Monsarrat
Danila Valmori
Pedro Romero
Jean-Charles Cerottini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Centre National de la Recherche Scientifique CNRS
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Centre National de la Recherche Scientifique CNRS
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Centre National de la Recherche Scientifique CNRS, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP1395276A1 publication Critical patent/EP1395276A1/de
Publication of EP1395276A4 publication Critical patent/EP1395276A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP02731790A 2001-05-15 2002-05-14 Struktur-modifizierte peptide und ihre verwendungen Withdrawn EP1395276A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29064601P 2001-05-15 2001-05-15
US290646P 2001-05-15
PCT/US2002/015217 WO2002092120A1 (en) 2001-05-15 2002-05-14 Structurally modified peptides and uses thereof

Publications (2)

Publication Number Publication Date
EP1395276A1 EP1395276A1 (de) 2004-03-10
EP1395276A4 true EP1395276A4 (de) 2004-12-29

Family

ID=23116948

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02731790A Withdrawn EP1395276A4 (de) 2001-05-15 2002-05-14 Struktur-modifizierte peptide und ihre verwendungen

Country Status (2)

Country Link
EP (1) EP1395276A4 (de)
WO (1) WO2002092120A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
US9314516B2 (en) * 2010-05-04 2016-04-19 Cassian Yee Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033511A1 (en) * 1997-02-05 1998-08-06 Ludwig Institute For Cancer Research Structurally modified peptides resistant to peptidase degradation
WO2001070772A2 (fr) * 2000-03-23 2001-09-27 Pierre Fabre Medicament Molecule d'interet pharmaceutique comportant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
EP0735893B1 (de) * 1993-09-14 2008-11-26 Pharmexa Inc. Pan dr-bindeproteinen zur erhöhung der immunantwort
US6218363B1 (en) * 1996-08-28 2001-04-17 Thomas Jefferson University MHC peptides and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033511A1 (en) * 1997-02-05 1998-08-06 Ludwig Institute For Cancer Research Structurally modified peptides resistant to peptidase degradation
WO2001070772A2 (fr) * 2000-03-23 2001-09-27 Pierre Fabre Medicament Molecule d'interet pharmaceutique comportant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
AYYOUB MAHA ET AL: "Analysis of the degradation mechanisms of MHC class I-presented tumor antigenic peptides by high performance liquid chromatography/electrospray ionization mass spectrometry: Application to the design of peptidase-resistant analogs", RAPID COMMUNICATIONS IN MASS SPECTROMETRY, vol. 12, no. 9, 1998, pages 557 - 564, XP008037828, ISSN: 0951-4198 *
BECK A ET AL: "Stability and CTL activity of N-terminal glutamic acid containing peptides.", THE JOURNAL OF PEPTIDE RESEARCH : OFFICIAL JOURNAL OF THE AMERICAN PEPTIDE SOCIETY. JUN 2001, vol. 57, no. 6, June 2001 (2001-06-01), pages 528 - 538, XP002303302, ISSN: 1397-002X *
BIANCO A ET AL: "N-Hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities.", JOURNAL OF PEPTIDE SCIENCE : AN OFFICIAL PUBLICATION OF THE EUROPEAN PEPTIDE SOCIETY. DEC 1998, vol. 4, no. 8, December 1998 (1998-12-01), pages 471 - 478, XP008037890, ISSN: 1075-2617 *
BLANCHET J S ET AL: "A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 NOV 2001, vol. 167, no. 10, 15 November 2001 (2001-11-15), pages 5852 - 5861, XP002303301, ISSN: 0022-1767 *
BRINCKERHOFF L H ET AL: "Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER. 29 OCT 1999, vol. 83, no. 3, 29 October 1999 (1999-10-29), pages 326 - 334, XP002303298, ISSN: 0020-7136 *
GUICHARD G ET AL: "Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes.", JOURNAL OF MEDICINAL CHEMISTRY. 5 OCT 2000, vol. 43, no. 20, 5 October 2000 (2000-10-05), pages 3803 - 3808, XP002303299, ISSN: 0022-2623 *
QUESNEL A ET AL: "Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART-1 protein.", JOURNAL OF PEPTIDE SCIENCE : AN OFFICIAL PUBLICATION OF THE EUROPEAN PEPTIDE SOCIETY. MAR 2001, vol. 7, no. 3, March 2001 (2001-03-01), pages 157 - 165, XP008037820, ISSN: 1075-2617 *
See also references of WO02092120A1 *
VALMORI D ET AL: "ENHANCED GENERATION OF SPECIFIC TUMOR-REACTIVE CTL IN VITRO BY SELECTED MELAN-A/MART-1 IMMUNODOMINANT PEPTIDE ANALOGUES", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 160, no. 4, 1998, pages 1750 - 1758, XP000887160, ISSN: 0022-1767 *

Also Published As

Publication number Publication date
WO2002092120A1 (en) 2002-11-21
EP1395276A1 (de) 2004-03-10

Similar Documents

Publication Publication Date Title
EP1549332A4 (de) Modifizierte asialo-interferone und ihre verwendungen
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
NO2012018I2 (no) Canakinumab eller direkte ekvivalenter derav
EP1556029A4 (de) Thiomolybdat-analoga und ihre verwendungen
EP1298180A4 (de) Hydrophobe und lipophobe zusammensetzung
DK1746375T3 (da) Oxygendrevet forbrændingssystem og anvendelser deraf
DE60200616D1 (de) Gesicherte Inhaltsobjekte
NO20003968D0 (no) Farmasøytiske preparater
DE60212275D1 (de) Wäschtrockner
DE50211426D1 (de) Trockner
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
EP1699485A4 (de) Anti-hydrolysat-antikörper und ihre verwendungen
NO20030239L (no) Modifisert virus
EP1478761A4 (de) Abbau hydrophober esterpestizide und -toxine
DK200100240U3 (da) Hvidløgsknuser
NO20041984L (no) Stenter
DE60228589D1 (de) Trockner
EP1395276A4 (de) Struktur-modifizierte peptide und ihre verwendungen
DE60138936D1 (de) Endabdichtung von Konditionierungswalzen
FR2834991B1 (fr) Nouveaux anticorps anti-igf-ir et leurs applications
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
EP1409551A4 (de) Chimere kapsidproteine und deren verwendung
EP1451216A4 (de) Mit dem immunsystem wechselwirkende moleküle und deren verwendungen
EP1299327A4 (de) Phosphorylierte polypeptide und ihre verwendung
DE10296144D2 (de) Koffer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 38/17 B

Ipc: 7C 07K 14/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20041116

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050203